Skip to content
Research Article Open access CC BY 4.0

Newly Exposed Membrane Glycoprotein II β (CD41) on Activated Platelets has Higher Affinity for Plasma Fibrinogen that Blocks Anti-CD41 Binding

Anugya Bhatt, Lissy K. Krishnan

International Blood Research & Reviews · pp. 1–11 · Published 5 Nov 2014

10.9734/IBRR/2015/13147

Abstract

The density of glycoprotein receptors on platelet membrane is dynamic and increase upon platelet activation by various stimulants to facilitate more ligand binding and functional outcome. Since CD41/61 receptor complex is responsible for platelet to platelet cross-linking, infusion of antagonists/antibodies against these molecules is considered an effective method for inhibiting platelet aggregation in certain clinical conditions. However, binding of anti-CD41 to the platelets stored in bags for transfusion was found to be lower. Probably, upon stimulation the newly exposed receptors may immediately bind fibrinogen and prevent access to the antibody. To prove this hypothesis, binding intensity of FITC-conjugated human fibrinogen to resting and stimulated platelets were compared using flow cytometry. In the presence of plasma fibrinogen, monoclonal antibody binding to the CD41 receptor decreased significantly, both onto the stored and agonist-activated platelets as compared to the resting cells. As compared to ADP-activated platelets, binding of anti-CD41 to thrombin-activated platelets was significantly lower. Variable binding intensity of anti-CD41 to platelets activated by different stimulants observed in this study allowed us to suggest that therapeutic antibodies also may not bind to platelets that are stimulated by strong agonists.  Our results signify the importance of validating such antibodies under conditions of stronger activation of platelets. We observed that more platelet microparticles (PMP) were shredded upon in vitro platelet activation by thrombin as compared to induction by ADP. However, fibrinogen did not bind to the shredded microparticles Therefore; PMP in circulation may not take part in pathological thrombus formation.  

Platelet glycoproteins flow cytometry platelet activation fibrinogen binding platelet activation markers

References (15)

  1. 1 Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty [DOI]
  2. 2 Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation. [DOI]
  3. 3 Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions [DOI]
  4. 4 Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets [DOI]
  5. 5 The Role of Platelets in Atherothrombosis [DOI]
  6. 6 Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases [DOI]
  7. 7 Integrin αIIbβ3 [DOI]
  8. 8 Platelet hyperactivity in type 2 diabetes: role of antiplatelet agents [DOI]
  9. 9 Pharmacodynamic Profile of Short-term Abciximab Treatment Demonstrates Prolonged Platelet Inhibition With Gradual Recovery From GP IIb/IIIa Receptor Blockade [DOI]
  10. 10 Platelet Glycoprotein IIb/IIIa Antagonists [DOI]
  11. 11 Quantification of Platelet Activation Status by Analyzing P-Selectin Expression [DOI]
  12. 12 Resting platelets contain a substantial centrally located pool of glycoprotein IIb-IIIa complex which may be accessible to some but not other extracellular proteins. [DOI]
  13. 13 Orbofiban: An orally active GPIIb/IIIa platelet receptor antagonist [DOI]
  14. 14 Activating Effects of GPIIb/IIIa Blockers: An Intrinsic Consequence of Ligand- Mimetic Properties [DOI]
  15. 15 Procedure for quantification of platelet adhesion to biomaterials by radioscintigraphy [DOI]

Cited by 1

PLATELET PROTEINS FROM DIABETIC SUBJECTS CAUSE PHENOTYPIC CHANGES IN ENDOTHELIAL CELLS IN-VITRO

Serene Hilary, J. Kesavadev, Anugya Bhatt · 2016

Related research

Article metrics

Real usage data collected on this platform.

63

Page views

0

PDF downloads

10

Outbound clicks

1

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.